主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
SPRY
#2144
ARS Pharmaceuticals, Inc. Common Stock
9.297
0
-1.62%
版块:
基础:
利润货币:
日范围
年范围
日变化
-1.62%
每月变动
-11.46%
6个月变化
+0.94%
年变化
+0.94%
前一天收盘价
9.450
0
Open
9.280
0
Bid
Ask
Low
9.280
0
High
9.297
0
交易量
101
市场
股票
医疗保健
SPRY
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
35.14 M
94.4 M
96.5 M
98.12 M
—
Valuation ratios
Enterprise value
—
584.36 M
467.51 M
984.35 M
4.79 B
Price to earnings ratio
—
-9.68
-9.79
131.88
5.23
Price to sales ratio
—
255.65
17.71 K
12.12
48.16
Price to cash flow ratio
—
8.39
8.96
79.73
135.18
Price to book ratio
—
1.23
2.3
4.21
8.76
Enterprise value to EBITDA ratio
—
—
—
—
—
Profitability ratios
Return on assets %
0.27
0.12
0.23
0.02
0.29
Return on equity %
0.29
0.13
0.24
0.03
0.6
Return on invested capital %
490.45
367.52
7 803.52
118.26
—
Gross margin %
100
100
100
100
400
Operating margin %
84.51 K
2 698.78
225.07 K
3.46
878.38
EBITDA margin %
—
—
—
—
—
Net margin %
84.41 K
2 635.41
181.22 K
8.97
829.44
Liquidity ratios
Quick ratio
—
—
—
14.04
36.7
Current ratio
17.56
51.01
96.92
14.26
38.09
Inventory turnover
—
—
—
0
—
Asset turnover
0
0
0
0.31
0.47
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
0
0
—
—
—
Long term debt to total equity ratio
0
0
—
—
—
Per share metrics
Operating cash flow per share
—
1
0.62
0.13
1.15
EBIT per share
—
—
—
—
—
EBITDA per share
—
—
—
—
—
Total debt per share
—
—
—
—
—
Cash per share
—
6.87
2.4
3.07
11.24
Net current asset value per share
—
6.95
2.43
3.26
12.65
Tangible book value per share
—
6.83
2.42
2.44
7.87
Working capital per share
—
6.81
2.41
3.04
11.17
Book value per share
—
6.83
2.42
2.51
8.29
新闻
ARS Pharmaceuticals Stock: Climbing Neffy Sales Global Expansion Re-Rate (NASDAQ:SPRY)
What's Going On With ARS Pharmaceuticals Stock Friday? - ARS Pharmaceuticals (NASDAQ:SPRY)
Why Is Aquestive Therapeutics Stock Falling Today? - Aquestive Therapeutics (NASDAQ:AQST)
中国批准首款社区使用的过敏反应鼻喷雾剂
China approves first community use epinephrine nasal spray for allergies
ARS制药公司首席商务官Chakma出售价值147万美元股票
Dorsey,ARS Pharma首席运营官出售价值19万美元SPRY股票
ARS Pharma CBO Chakma sells shares worth $1.47 million
Dorsey, ARS Pharma COO, sells $190k in SPRY stock
ARS Pharmaceuticals, Inc. (SPRY) Q3 2025 Earnings Call Transcript
ARS制药公司股价因强劲第三季度销售额上涨,Raymond James重申强力买入评级
William Blair重申ARS制药公司"跑赢大盘"评级,基于neffy数据